245 results about "Zingiber officinale" patented technology

The present invention relates to a formulation of herbal toothpowder or toothpaste for gums and teeth, which comprises of powder or paste of Zanthoxylum armatum (20-25%), Zingiber officinale (25-30%), Santalum album (8.25-8.5%), Spilanthes calva (2.0-2.5%), Pistacia lentiseus (2.0-2.5%), Quercus infectoria (8.0-8.5%), Usnea longissima (1-4%), as well as roasted alum and common salt.

An anti-cough, anti-tussive, and throat soothing synergistic herbal formulation comprising of an extract of Piper cubeba, Glycyrrhiza glabra, Acorus calamus Alpinia galanga, Zingiber officinale and pharmaceutically acceptable additives as a syrup, lozenges or chewable tablets for preventing cracking of voice, dryness of mouth and toning of voice, vocal cord; the present invention also provides a method of preparation of this formulation.

The present invention relating to a herbal antiallergic composition which comprises a synergistic mixture of extracts from the fruits of Terminalia chebula, bark of Albizia lebbeck, Terminalia bellerica and Emblica officinalis. The present invention also contains the fruits of Piper longum, Piper nigrum and of rhizomes of Zingiber officinale and thoroughly mixed to get the final composition which has potent antiallergic activity. The invention also relates to a process for the preparation of such composition. The composition is particularly useful for the treatment of allergic conditions.

The present invention relates to a bio-pesticide comprising a mixture of natural spices that kills insects through direct contact. Piper Nigrum, Cuminum Cyminum, Cinnamomum Verum, Allium Sativum, Coriandrum Sativum, Curcuma, Foeniculum Vulgare, Trigonella Foenum Graecum, Syzygium Aromaticum, Capsicum, Zingiber Officinale, Murraya Koenigii, Brassica Nigra, and Sodium Chloride are mixed with potting soil and applied to a plant. The bio-pesticide works through the processes of repellency, digestive inhabitancy, paralysis and suffocation. The bio-pesticide can be applied as a dust or liquid spray to the plants, and can eliminate the pests within 48-72 hours.

This invention discloses a method of use for a topical herbal formulation alone or in combination with oral administration of niacin (preferably a flush preparation) to prevent and/or treat dyshidrosis (pompholyx) and related skin diseases. The formulation may also be used to treat contact dermatitis, eczema, palmoplantar pustulosis and skin infections incurred by invasive pathogens such as mold, fungus and bacteria. The formulation is comprised of plant extracts and niacin, that when combined yield an effective multi-faceted pharmaceutical approach to treating dry skin disorders. The active ingredients within the formula include a combination of dry, aqueous, acid and alcohol extracts of black walnut hull (Juglans nigra), wormwood (Artemisia absinthium), tumeric rhizome (Curcuma longa), garlic (Allium sativum), two or more herbal antibacterial agents from the group consisting of chamomile (Matricaria Chamomile), licorice root (Glycyrrhiza glabra), St Johns wort (Hypericum perforatum), clove (Syzygium aromaticum), nutmeg (Myristica fragans), ginger (Zingiber officinale), frankincense (Boswellia carteri) and myrrh (Commiphora molmol), further combined with aloe vera and niacin.

The invention relates to a Chinese medicinal composition for treating gastrointestinal tract diseases, which is prepared from the following raw materials (by weight ratio): banksia rose, linaloe, bitter orange, magnolia bark each 2-20 parts, Chinese date 10-60 parts, musk 0.1-0.8 part, defatted powder of croton seed 1-10 parts, sandalwood 1-10 parts, rheum officinale 1-10 parts, rhizome of Sichuan lovage 1-10 parts and cinnabar 1-10 parts.

The present invention provides a novel nicotine free anticigarette herbal formulation as an anti-dote to the poisoning effects of tobacco products such as Cigarettes, Gutka, Pan masala and other similar tobacco related products. Formulation(s) comprises of sterilized dried plant powder/extracts together with the conventional additives to form the oral dosage forms, which include tablets, capsules, syrup and powders ready for suspension and mouth spray. The anti tobacco addiction herbal formulation comprises of Sesbania grandiflora, Catharanthus roseus, Ocimum sanctum, Myristica fragrans, Elettaria cardamomum, Carum copticum, Syzgium aromaticum, Cinnamomum tamala, Acorus calamus, Zingiber officinale, Piper nigrum, Cinnamomum zeylanicum, Cuminum cyminum, Nigella sativum, Cinnamomum camphora, Piper longum Ocimum gratssimum and Hemidesmus indicus.

The invention as presently conceived discloses a chemical formula for the composition of a liquid topical analgesic. It is produced from a unique blend of herbal essential oils and plant- and/or vegetable-derived oils. Although the precise proportions and method of mixture are held in confidence, it comprises at least olive oil, castor oil, grapeseed oil, almond oil, apricot kernel oil, Vitamin E, various herbal essential oils, and a stabilizer. Such essential oils may include eucalyptus (Eucalyptus globulus, among others), lavender (Lavandula angustifolia), tea tree (Melaleuca alternifloria), ginger (Zingiber officinale), lemongrass (Cymbopogon citratus, among others), red thyme (Thymus vulgaris), sweet birch, (Betula lenta) and ylang ylang (Cananga odorata). Alternate and additional essential oils or plant- and/or vegetable-derived oils are anticipated to be used as well. When produced, the mixture would be bottled and promoted to the public to be used as a topical rubbing compound for the skin or for use in a soaking bath. It will reduce pain from sore muscles, bruised ligaments and tendons, lower back pain, arthritis and other similar ailments associated with common aches and pains.

The invention discloses a Chinese herbal medicinal formula with effects of alopecia resistance and hair growth. The Chinese herbal medicinal formula comprises a first component which comprises 1800-2500g of Chinese angelica, 900-1500g of Syzygium aromaticum, 900-1500g of Panax ginseng, 2000-3000g of Zingiber officinale Roscoe, 1000-1500g of Zanthoxylum bungeanum, 500-800g of Ganoderma lucidum, 2000-3000g of licorice, 1000-1500g of Gastrodia elata Blume; and a second component which comprises 1800-2500g of Semen Sesami Nigrum, 800-1300g of Gleditasia sinesis Lam, 800-1300g of Carthamus tinctorius L., 1000-1500g of Semen Ginko, 2000-3000g of Fallopia multiflora (Thunb.) Harald, 1000-1500g of Rheum palmatum L., and 2000-3000g of Platycladus orientalis. The formula is prepared by technologiesof immersion of above raw materials with ethanol, distillation, filtration, blending and the like. A product with the formula of the invention has good effects of alopecia resistance and hair growth,can effectively break through problems of thickness and firmness of hair. Compared with products of a same kind in the market, the product of the invention has a lasting curative effect and is safe and nontoxic.

Herbal compositions having anti-adipocyte fatty acid-binding protein (aP2), anti-5-lipoxygenase-activating protein (FLAP) and anti-Cysteinyl Leukotriene (CysLT)-1 receptor expression activity contain an extract of Boswellia serrata. More particularly, these herbal compositions comprise an effective amount of an enriched Boswellia extract containing from 10% to 99% by weight of 3-0-acetyl-11-keto-β-boswellic acid; and an effective amount of a second extract selected from the group consisting of an extract of Aegle marmelos, an extract of Zingiber officinale, an extract of Garcinia mangostana, and mixtures thereof. These may be used in dietary supplements or pharmaceutical formulations for controlling diseases associated with or related to inflammation. These diseases in particular include respiratory disorders such as asthma, allergic rhinitis, hay fever, type-1 hypersensitivity and mild allergies. The compositions can also be useful for skin care.

This invention discloses a Schisandra chinensis grape wine, which is prepared from: fresh grape 50-70 wt.%, Schisandra chinensis 5-8 wt.%, lecithin 2-6 wt.%, Zingiber officinale 2-4 wt.%, Siraitia grosvenorii 2-5 wt.%, Glycyrrhiza 3-6 wt.%, Zizyphus jujube 2-4 wt.%, yeast 3-7 wt.%, and sugar 10-18 wt.%. The preparation method comprises: pulverizing the raw materials, mixing adequately, sending into a fermentation jar, and sealing, fermenting, and pressing the fermented product to obtain crude wine, filtering, precipitating, sterilizing the supernatant, measuring, and packaging. The obtained Schisandra chinensis grape wine has good flavor and high nutrition of grape and other raw materials, and has healthcare function. This invention has such advantages as simple preparation method, and short production cycle.

A method for prevention or therapy of pollen allergy, allergic rhinitis, atopic dermatitis, asthma or urticaria by administration of two kinds of crude drugs—seeds of Cucurbita moschata and flowers of Carthamus tinctorius—and at least one crude rug selected from Plantago asiatica, Lonicera japonica, Glycyrrhiza uralensis, Coix lachrymal-jobi var. ma-yuen, Zingiber officinale, Curcuma longa, Curcuma zedoaria and Artemisia argyi to a patient; and a health food for prevention, or improvement, or reduction of these symptoms containing the above substances.

The invention provides a preparation method of hot pot red oil, which has a recipe consisting of vegetable oil, star anise, galangal, long pepper, lithospermum, citronella, spiceleaf, kaempferiae, elecampane, pericarpium zanthoxyli, citron, amomun kravanh, dried orange peel, angelica dahurica, xin dogwood flowers, camphortree root, grass shell ginkgo, cinnamon, fructus amomi globosi, Shuizhizi, ageratum, cumin, common fennel, liquorice, pepper, rhizoma zingiberis, amomum villosum, angelica, longan, allspice, muscade, clove, ginkgo, wild pepper, purple cardamomum and meat cardamomum. The hot pot red oil of the invention has unique taste, eaters have rich mouth feelings, the hot pot red oil has strong fragrance and long aftertaste, and in addition, the hot pot red oil has good health care effect. The manufacture method is simple, the cost is low, the hot pot red oil can be instantly eaten after being made, and sterilization can also be carried out after the hot pot red oil are bagged. The hot pot red oil of the invention can be used for seasoning various hot pots, and can be prepared into different flavors as required to meet the requirements of different regions and different eating habits.

The present invention relates to a bio enhancing composition containing extract and/or bioactive fraction/isolate from the plant Zingiber officinale in combinations combination with drugs, nutrients, nutraceuticals, micronutrients and herbal drugs/products and optionally containing piperine as a extract/active fraction obtained from piper nigrum, piper longum or its oleoresin as a bioavailability enhancer and its process for producing the extract or fractions from the plant source.

Novel compositions which are useful in the treatment of mammals for the reduction of inflammation, especially in the gut, and which comprise an aqueous extract of an agricultural product. Preferred compositions comprise an aqueous extract of olive, or an aqueous extract of ginger. The compositions can optionally contain an aqueous extract of chamomile and/or an aqueous extract of artichoke and/or an aqueous extract of cinnamon.

The present invention provides a novel blend of essential oils and herbs. A blend of the invention may be used to treat nausea. A blend of the invention may be used to provide a calming, soothing feeling. Optionally the novel blend of the invention is introduced into the body of a person by inhalation. In one aspect of the invention, the novel blend of essential oils and herbs includes Mentha piperita (peppermint), Mentha spicata (spearmint), Zingiber officinale (ginger), and Lavandula angustifolia (lavender), as well as the herbs Lavandula angustifolia (lavender), Ocimum basilicum (basil), Artemesia dracunculus (tarragon) and Mentha spicata (spearmint).

The present invention relates to a pharmaceutical or a food composition for inducing or stimulating secretion of insulin-like growth factor-1. More particularly, the present invention relates to compositions for inducing or stimulating secretion of insulin-like growth factor-1, which comprises (a) a pharmaceutically effective amount of an extract obtained from oriental pharmaceutical selected from the group consisting of Phlomis umbrosa Turez, Cynanchum wilfordii(Max) Hem≦, Zingiber officinale Rosc., Platycodi Radix and combination thereof; and (b) a pharmaceutical acceptable carrier.

A medicinal composition comprising an apportioned combination of at least eight essential oils selected from the group consisting of calophyllum inophyllum, citrus aurantium, eucalyptus globulublus, eugenia caryophyllata, foeniculum vulgare, helichrysum angustifolia, juniperus virginiana, lavendula officinalis, muristica fragrans, ocimum basilicim, pinus sylvestrius, piper nigrum, rosemarinus officinalis, salvia officinalis lamiacae, salvia sclarea and zingiber officinale. When configured for topical dermal application, this composition has been shown to be therapeutically effective at relieving pain.

The invention provides a novel herbal composition for treatment of arthritis and inflammation. The herbal composition comprises a therapeutically effective combination of extracts obtained from the plants Terminalia chebula, Pluchea lanceolata, Desmodium gangeticum, Vitex negunto and Zingiber officinale, optionally along with pharmaceutically acceptable additives. The invention further comprises methods of making the herbal composition and methods of use for the treatment of arthritis and inflammation.

A composition for administration to a subject with dry eye or a dry eye-associated ocular condition is disclosed. The composition includes a botanical active agent in an amount effective for treating, preventing, and/or ameliorating dry eye or a dry eye-associated ocular condition in a subject upon administration of the composition thereto. The botanical active agent comprises a Zingiber officinale extract, an Eriobotrya japonica extract, or combinations thereof. The composition may be adapted for oral administration to the subject, and formulated as a nutraceutical, pharmaceutical, or supplement, e.g. in a single dosage form of a capsule or softgel. A method of treating, preventing, and/or ameliorating dry eye or a dry eye-associated ocular condition in a subject is also disclosed. The method comprises administering an effective amount of the composition to a subject.

The present invention relates generally to plant extracts and/or components isolated therefrom which exhibit desirable properties in relation to therapy and/or food technology. More particularly, the present invention relates to extracts and components isolated thereof from the plant genus Zingiber and in particular from the rhizome of the species Zingiber officinale (also known as ginger) which comprise activities having broad applicability in the fields of research reagents, inter alia pharmaceutical and/or nutraceutical product development, manufacture of improved high-value food and feed products, production of alcohol from cereals and waste treatment.

The invention discloses a traditional Chinese medicine composition for treating obesity. The traditional Chinese medicine composition is prepared from the following bulk pharmaceutical chemicals: talcum, rhizome atractylodis macrocephalae, radix platycodi, Chinese herbaceous peony, radix scutellariae, gypsum fibrosum, radix glycyrrhizae, radix angelicae sinensis, radix saposhnikoviae, herba ephedrae, rhizoma chuanxiong, fructus gardeniae, fructus forsythiae, herba schizonepetae, rhizoma zingiber officinale, raw rhubarb root and stem, natrii sulfas, cortex magnoliae officinalis and fructus aurantii immaturus. The invention further provides application of the traditional Chinese medicine composition. The traditional Chinese medicine composition has the advantages that: the bulk pharmaceutical chemicals are reasonably combined, and obesity and endomorphy type polycystic ovarian syndrome can be effectively treated under comprehensive action of the bulk pharmaceutical chemicals. The traditional Chinese medicine composition disclosed by the invention is excellent in curative effect, is small in side effects, can be for used for a long time, and has a wide clinical popularization value.

The invention relates to a preparation process of integration-type novel formulation of XIAOBANXIA decoction and a production method thereof. The effective components of the novel formulation are made from the following raw materials (by weight parts): Pinellia ternate 18 and Zingiber officinale 15. The production method includes the steps of supersonic airstream pulverization, alcohol-water extraction, ultrasonic pulverization and extraction, water decoction and concentration, supersonic spray-drying, nano-scale grinding, high-pressure emulsion and homogenization and nanoparticle preparation. The production method integrates the advantageous of the nano-carrier combination technique, such as multi-component synergism and multi-target. The large-scale production can greatly reduce the production cost, greatly improve the product quality and enhance the target property and sustained/controlled-release property of drugs. The novel formulation is administered by oral intake and external application during four time periods respectively based on the midnight-noon tidal flow and human qi-blood flow rule. The novel formulation is also processed to membranes and transdermal delivery agents which are applied to different parts of human body respectively according to the midnight-noon tidal flow and human qi-blood flow rule and can be directly absorbed by the skin.